Table 1.
Drug | n (patients) | OS (mo) | HR |
SOR/Exp arm | |||
First line completed (Sorafenib standard) | |||
Brivanib | 1155 | 9.9/9.5 | 1.06 |
Sunitinib | 1074 | 10.2/7.9 | 1.3 |
Sorafenib/Erlotinib | 720 | 8.5/9.5 | 0.92 |
Linifanib | 1035 | 9.8/9.1 | 1.04 |
Second line completed (placebo standard) | |||
Brivanib | 395 | 8.2/9.4 | 0.89 |
Everolimus | 546 | 7.3/7.6 | 1.05 |
Ramucirumab | 565 | 7.6/9.2 | 0.86 |
OS: Overall survival; SOR: Sorafenib arm.